Ondine Biomedical (OBI) Competitors

Ondine Biomedical (LON:OBI) and PureTech Health (LON:PRTC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

Which has better earnings and valuation, OBI or PRTC?

Ondine Biomedical has higher earnings, but lower revenue than PureTech Health. PureTech Health is trading at a lower price-to-earnings ratio than Ondine Biomedical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ondine Biomedical	C$48.60K	2,367.27	-C$424.66K	-C$3.32	-4.82
PureTech Health	£521.32K	798.60	-£91.86M	-£24.38	-5.69

Do institutionals and insiders believe in OBI or PRTC?

20.6% of Ondine Biomedical shares are held by institutional investors. Comparatively, 79.9% of PureTech Health shares are held by institutional investors. 36.7% of Ondine Biomedical shares are held by company insiders. Comparatively, 15.9% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Do analysts prefer OBI or PRTC?

PureTech Health has a consensus target price of GBX 455, indicating a potential upside of 228.28%. Given PureTech Health's stronger consensus rating and higher possible upside, analysts clearly believe PureTech Health is more favorable than Ondine Biomedical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ondine Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
PureTech Health	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer OBI or PRTC?

In the previous week, PureTech Health had 1 more articles in the media than Ondine Biomedical. MarketBeat recorded 3 mentions for PureTech Health and 2 mentions for Ondine Biomedical. Ondine Biomedical's average media sentiment score of 0.45 beat PureTech Health's score of 0.00 indicating that Ondine Biomedical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ondine Biomedical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PureTech Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is OBI or PRTC more profitable?

Ondine Biomedical has a net margin of -873.84% compared to PureTech Health's net margin of -17,620.94%. PureTech Health's return on equity of -21.15% beat Ondine Biomedical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ondine Biomedical	-873.84%	-684.01%	-159.71%
PureTech Health	-17,620.94%	-21.15%	-13.39%

Which has more volatility and risk, OBI or PRTC?

Ondine Biomedical has a beta of 0.1, indicating that its stock price is 90% less volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Summary

PureTech Health beats Ondine Biomedical on 9 of the 16 factors compared between the two stocks.